Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-09-27
1984-03-20
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 3127
Patent
active
044381344
ABSTRACT:
Warm-blooded animals are treated for Herpes Simplex Virus-I by administering to the animal a dosage, effective to alleviate the symptoms of the virus, of Tolnaftate (chemically called 0-2-naphthyl-m,N-dimethylthio carbanilate) and at least one pharmaceutically acceptable carrier, wherein the compound is in the range of from about 0.01 to about 95% by weight of the composition.
REFERENCES:
Chemical Abstracts 88: 158482k (1978).
The Merck Index 9th Ed., 1976, Merck & Co., Inc., Rahway, N.J., p. 1224.
Goldberg Jerome D.
Pennwalt Corporation
LandOfFree
Use of tolnaftate to treat herpes labialis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of tolnaftate to treat herpes labialis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tolnaftate to treat herpes labialis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1604041